High materiality7/10
RBC Capital on Neurocrine Bio. (NBIX): 'We like the setup and remain buyers'
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital targets $198; posted price $155.66.
- RBC Capital Buy; target $198; price $155.66
Key facts
- 01
Target: $198
- 02
Posted price: $155.66
- 03
Analyst firm: RBC Capital
- 04
Analyst: Brian Abrahams
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.